Kadmon

November 04, 2019

SITC 2019 preview – Pieris joins the quest for a better Herceptin

Any signs of efficacy with PRS-343 could help Pieris claw back some of its recent losses, but Her2 targeting is increasingly competitive.

November 01, 2019

Upcoming events – key tests approach for Kadmon and Surface

Kadmon awaits key graft-versus-host disease data, and Surface Oncology's change of tack comes under the spotlight.

February 13, 2018

Kadmon's lung disease card is not quite an ace

April 11, 2017

Calling time on biotech’s shady stock-promotion schemes

The US regulator has come down surprisingly hard on biotech stock promotion schemes.

January 24, 2017

Investors in new issues embrace 2016’s new reality

December 07, 2016

World Lung – Companies look to fill brain metastasis niche

December 05, 2016

Reneuron keeps faith with stem cell stroke project

November 18, 2016

Upcoming events – Reneuron’s time to deliver and Kadmon targets metastases

October 19, 2016

Biotech IPO market remains open but investors prove picky eaters

February 03, 2016

No safe haven as January crash wipes $644bn off biopharma

August 15, 2012

Event – Aegerion looks to US panel for business validation